{"entity":{"type":"insider","cik":"0001430788","url":"/insider/0001430788","json_url":"/insider/0001430788.json","name":"Carmine Bryce D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":16,"first":"2010-08-18","last":"2011-12-14","span_basis":"filed_date"},"name_variants":[{"name":"Carmine Bryce D.","source":"filing","n_filings":16,"first_seen":"2010-08-18","last_seen":"2011-12-14"}],"transactions":[{"id":9036116,"accession":"0001209191-11-061194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-061194","line_url":"/filing/0001209191-11-061194#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5787.0,"shares_display":"5,787","price_per_share":39.1,"price_display":"39.10","price_state":"stated","total_value":226271.7,"total_display":"226,271.70","total_whole":"226,272","shares_owned_after":51266.0,"shares_owned_after_display":"51,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-12","filed_date":"2011-12-14","scope":"insider"},{"id":8854067,"accession":"0001209191-11-055635","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-055635","line_url":"/filing/0001209191-11-055635#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":37.55,"price_display":"37.55","price_state":"stated","total_value":214035.0,"total_display":"214,035.00","total_whole":"214,035","shares_owned_after":57053.0,"shares_owned_after_display":"57,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-11","filed_date":"2011-11-14","scope":"insider"},{"id":9133715,"accession":"0001209191-11-051643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-051643","line_url":"/filing/0001209191-11-051643#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":38.1,"price_display":"38.10","price_state":"stated","total_value":217170.0,"total_display":"217,170.00","total_whole":"217,170","shares_owned_after":62753.0,"shares_owned_after_display":"62,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-11","filed_date":"2011-10-13","scope":"insider"},{"id":8960877,"accession":"0001209191-11-047782","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-047782","line_url":"/filing/0001209191-11-047782#line-2","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":35.91,"price_display":"35.91","price_state":"stated","total_value":204687.0,"total_display":"204,687.00","total_whole":"204,687","shares_owned_after":68453.0,"shares_owned_after_display":"68,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-12","filed_date":"2011-09-14","scope":"insider"},{"id":9174982,"accession":"0001209191-11-043960","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-043960","line_url":"/filing/0001209191-11-043960#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":33.94,"price_display":"33.94","price_state":"stated","total_value":193458.0,"total_display":"193,458.00","total_whole":"193,458","shares_owned_after":74298.0,"shares_owned_after_display":"74,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-11","filed_date":"2011-08-12","scope":"insider"},{"id":8968919,"accession":"0001209191-11-039364","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-039364","line_url":"/filing/0001209191-11-039364#line-3","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":37.39,"price_display":"37.39","price_state":"stated","total_value":213123.0,"total_display":"213,123.00","total_whole":"213,123","shares_owned_after":79998.0,"shares_owned_after_display":"79,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-11","filed_date":"2011-07-13","scope":"insider"},{"id":8928434,"accession":"0001209191-11-034699","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-034699","line_url":"/filing/0001209191-11-034699#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":37.25,"price_display":"37.25","price_state":"stated","total_value":212325.0,"total_display":"212,325.00","total_whole":"212,325","shares_owned_after":86307.0,"shares_owned_after_display":"86,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-13","filed_date":"2011-06-15","scope":"insider"},{"id":9073711,"accession":"0001209191-11-028166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-028166","line_url":"/filing/0001209191-11-028166#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":38.21,"price_display":"38.21","price_state":"stated","total_value":217797.0,"total_display":"217,797.00","total_whole":"217,797","shares_owned_after":92007.0,"shares_owned_after_display":"92,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-11","filed_date":"2011-05-13","scope":"insider"},{"id":9191718,"accession":"0001209191-11-022593","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-022593","line_url":"/filing/0001209191-11-022593#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":35.76,"price_display":"35.76","price_state":"stated","total_value":203832.0,"total_display":"203,832.00","total_whole":"203,832","shares_owned_after":97707.0,"shares_owned_after_display":"97,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-11","filed_date":"2011-04-12","scope":"insider"},{"id":9150964,"accession":"0001209191-11-010612","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-010612","line_url":"/filing/0001209191-11-010612#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":34.49,"price_display":"34.49","price_state":"stated","total_value":106919.0,"total_display":"106,919.00","total_whole":"106,919","shares_owned_after":103407.0,"shares_owned_after_display":"103,407","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-16","filed_date":"2011-02-17","scope":"insider"},{"id":9191208,"accession":"0001209191-11-003397","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-003397","line_url":"/filing/0001209191-11-003397#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":34.87,"price_display":"34.87","price_state":"stated","total_value":108097.0,"total_display":"108,097.00","total_whole":"108,097","shares_owned_after":56930.0,"shares_owned_after_display":"56,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-14","filed_date":"2011-01-18","scope":"insider"},{"id":7332645,"accession":"0001209191-10-061374","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-10-061374","line_url":"/filing/0001209191-10-061374#line-4","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":35.1,"price_display":"35.10","price_state":"stated","total_value":108810.0,"total_display":"108,810.00","total_whole":"108,810","shares_owned_after":60030.0,"shares_owned_after_display":"60,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-16","filed_date":"2010-12-17","scope":"insider"},{"id":7368579,"accession":"0001209191-10-055440","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-055440","line_url":"/filing/0001209191-10-055440#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":34.43,"price_display":"34.43","price_state":"stated","total_value":106733.0,"total_display":"106,733.00","total_whole":"106,733","shares_owned_after":63340.0,"shares_owned_after_display":"63,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-16","filed_date":"2010-11-17","scope":"insider"},{"id":7476068,"accession":"0001209191-10-050849","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-050849","line_url":"/filing/0001209191-10-050849#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":37.65,"price_display":"37.65","price_state":"stated","total_value":116715.0,"total_display":"116,715.00","total_whole":"116,715","shares_owned_after":66440.0,"shares_owned_after_display":"66,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-15","filed_date":"2010-10-19","scope":"insider"},{"id":7639139,"accession":"0001209191-10-046772","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-046772","line_url":"/filing/0001209191-10-046772#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":35.55,"price_display":"35.55","price_state":"stated","total_value":110205.0,"total_display":"110,205.00","total_whole":"110,205","shares_owned_after":69540.0,"shares_owned_after_display":"69,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-16","filed_date":"2010-09-17","scope":"insider"},{"id":7351852,"accession":"0001209191-10-043118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-043118","line_url":"/filing/0001209191-10-043118#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001430788","owner_name":"Carmine Bryce D.","owner_display_name":"Carmine Bryce D.","owner_url":"/insider/0001430788","role":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark":"O","role_mark_label":"Officer (EVP and Pres, Lilly Bio-Meds)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Pres, Lilly Bio-Meds","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":35.33,"price_display":"35.33","price_state":"stated","total_value":109523.0,"total_display":"109,523.00","total_whole":"109,523","shares_owned_after":72640.0,"shares_owned_after_display":"72,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-16","filed_date":"2010-08-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000059478","name":"LILLY ELI & CO","url":"/issuer/0000059478","role":"Officer (EVP and Pres, Lilly Bio-Meds)","n_filings":16,"first_seen":"2010-08-18","last_seen":"2011-12-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001430788","retrieved_at":"2026-08-25T08:24:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}